JP2022533215A5 - - Google Patents
Info
- Publication number
- JP2022533215A5 JP2022533215A5 JP2021568944A JP2021568944A JP2022533215A5 JP 2022533215 A5 JP2022533215 A5 JP 2022533215A5 JP 2021568944 A JP2021568944 A JP 2021568944A JP 2021568944 A JP2021568944 A JP 2021568944A JP 2022533215 A5 JP2022533215 A5 JP 2022533215A5
- Authority
- JP
- Japan
- Prior art keywords
- indicates
- bond
- nhc
- independently selected
- spacer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025144373A JP2026000940A (ja) | 2019-05-20 | 2025-09-01 | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962850094P | 2019-05-20 | 2019-05-20 | |
| US62/850,094 | 2019-05-20 | ||
| PCT/US2020/033648 WO2020236841A2 (en) | 2019-05-20 | 2020-05-19 | Antibody drug conjugates having linkers comprising hydrophilic groups |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144373A Division JP2026000940A (ja) | 2019-05-20 | 2025-09-01 | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533215A JP2022533215A (ja) | 2022-07-21 |
| JP2022533215A5 true JP2022533215A5 (cg-RX-API-DMAC7.html) | 2023-05-26 |
Family
ID=71070004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568944A Pending JP2022533215A (ja) | 2019-05-20 | 2020-05-19 | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート |
| JP2025144373A Pending JP2026000940A (ja) | 2019-05-20 | 2025-09-01 | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144373A Pending JP2026000940A (ja) | 2019-05-20 | 2025-09-01 | 親水性基を含むリンカーを有する抗体薬剤コンジュゲート |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230091510A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3972650A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022533215A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220010527A (cg-RX-API-DMAC7.html) |
| CN (3) | CN119613486A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020279731B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3140063A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL287596A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020236841A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240238440A1 (en) * | 2021-04-29 | 2024-07-18 | Hyslink Therapeutics | Preparation method for and application of antibody conjugated drug |
| KR20240016287A (ko) | 2021-06-01 | 2024-02-06 | 아지노모토 가부시키가이샤 | 항체 및 기능성 물질의 콘쥬게이트 또는 이의 염, 및 이의 제조에 사용되는 화합물 또는 이의 염 |
| EP4349371A4 (en) * | 2021-06-02 | 2025-06-25 | Bio-Thera Solutions, Ltd. | DRUG CONJUGATE AND USE THEREOF |
| CN117500528A (zh) * | 2021-06-18 | 2024-02-02 | 北京海步医药科技有限公司 | 连接子及其缀合物 |
| EP4509141A4 (en) * | 2022-04-12 | 2026-08-19 | Bio Thera Solutions Ltd | TREATMENT METHOD FOR A HER2-POSITIVE SOLID TUMOR |
| KR20250011947A (ko) * | 2022-05-20 | 2025-01-22 | 노파르티스 아게 | 항체 약물 콘쥬게이트 |
| CA3266848A1 (en) * | 2022-10-19 | 2024-04-25 | Multitude Therapeutics Inc. | Antibodies, antibody-drug conjugates, preparations and uses thereof |
| CN116036303B (zh) * | 2023-01-10 | 2025-06-24 | 金麦安博生物制药(苏州)有限公司 | 一种抗体-药物偶联物及其制备方法和应用 |
| JP2026504840A (ja) * | 2023-01-11 | 2026-02-10 | ジェンマブ エー/エス | リンカー、薬物リンカー、およびそれらの複合体、ならびにそれらを使用する方法 |
| CN118852442A (zh) | 2023-04-26 | 2024-10-29 | 上海麦科思生物医药有限公司 | 抗ptk7抗体及其用途 |
| WO2025171055A1 (en) | 2024-02-06 | 2025-08-14 | Kumquat Biosciences Inc. | Heterocyclic conjugates and uses thereof |
| WO2025228305A1 (zh) * | 2024-04-28 | 2025-11-06 | 中国科学院上海药物研究所 | 一种蛋白降解剂缀合物及其偶联物 |
| KR20250164033A (ko) * | 2024-05-14 | 2025-11-24 | 주식회사 지놈앤컴퍼니 | 항-bcam 항체 및 이의 컨쥬게이트 |
| WO2025255381A1 (en) * | 2024-06-05 | 2025-12-11 | Sigma-Aldrich Co. Llc | Chito-oligosaccharide drug constructs |
| WO2026046186A1 (en) * | 2024-08-27 | 2026-03-05 | Suzhou Bioreinno Biotechnology Limited Company | Linkers, linker conjugates and conjugate compounds thereof |
| WO2026105061A1 (en) | 2024-11-15 | 2026-05-21 | Pheon Therapeutics Ltd | Antibody-drug conjugates that bind cdcp1 and uses thereof |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| JPH06507404A (ja) | 1991-05-01 | 1994-08-25 | ヘンリー エム.ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 感染性の呼吸性疾患の治療方法 |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| AU4116793A (en) | 1992-04-24 | 1993-11-29 | Board Of Regents, The University Of Texas System | Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US6132764A (en) | 1994-08-05 | 2000-10-17 | Targesome, Inc. | Targeted polymerized liposome diagnostic and treatment agents |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| US5985320A (en) | 1996-03-04 | 1999-11-16 | The Penn State Research Foundation | Materials and methods for enhancing cellular internalization |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6056973A (en) | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| DE69732306T2 (de) | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ,インコーポレイティド | 人工抗体ポリペプチド |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| JP4334141B2 (ja) | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| ES2198922T3 (es) | 1998-06-24 | 2004-02-01 | Advanced Inhalation Research, Inc. | Particulas porosas grandes emitadas por un inhalador. |
| HUP0104865A3 (en) | 1999-01-15 | 2004-07-28 | Genentech Inc | Polypeptide variants with altered effector function |
| EP2275540B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| PL213948B1 (pl) | 2001-10-25 | 2013-05-31 | Genentech Inc | Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje |
| BRPI1015234A2 (en) | 2009-06-22 | 2018-02-20 | Medimmune Llc | fc regions designed for site specific conjugation. |
| AU2013350802B2 (en) | 2012-11-30 | 2016-07-14 | Novartis Ag | Methods for making conjugates from disulfide-containing proteins |
| KR20210132742A (ko) * | 2012-12-21 | 2021-11-04 | 알트루바이오 인코퍼레이티드 | 친수성 자기-희생 링커 및 그것의 포합체 |
| EA201591465A1 (ru) | 2013-02-08 | 2015-12-30 | АйАрЭм ЭлЭлСи | Специфичные участки для модификации антител для получения иммуноконъюгатов |
| PT3057585T (pt) * | 2013-10-15 | 2020-10-21 | Seagen Inc | Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando |
| EP3125943B1 (en) * | 2014-04-04 | 2026-04-22 | Merck Sharp & Dohme LLC | Phosphate based linkers for intracellular delivery of drug conjugates |
| KR20170020868A (ko) * | 2014-06-20 | 2017-02-24 | 바이오얼라이언스 씨.브이. | 항-폴레이트 수용체 알파 (fra) 항체-약물 컨쥬게이트 및 그것의 사용 방법 |
| WO2015196089A1 (en) * | 2014-06-20 | 2015-12-23 | Bioalliance C.V. | Anti-cd22 antibody-drug conjugates and methods of using thereof |
| RU2017123942A (ru) * | 2014-12-09 | 2019-01-11 | Эббви Инк. | Ингибирующие bcl-xl соединения, обладающие низкой клеточной проницаемостью, и коньюгаты антитело-лекарственное средство, включающие их |
| US20190194315A1 (en) | 2015-06-17 | 2019-06-27 | Novartis Ag | Antibody drug conjugates |
| CN116059201A (zh) * | 2016-06-08 | 2023-05-05 | 艾伯维公司 | 抗egfr抗体药物偶联物 |
| CN108066772B (zh) * | 2016-11-14 | 2021-07-13 | 中国科学院上海药物研究所 | 靶向tacstd2的抗体与药物偶联体(adc)分子 |
| US11135307B2 (en) * | 2016-11-23 | 2021-10-05 | Mersana Therapeutics, Inc. | Peptide-containing linkers for antibody-drug conjugates |
| US10646585B2 (en) * | 2017-09-15 | 2020-05-12 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and ligand-drug conjugates thereof |
| EP3700577A1 (en) * | 2017-10-23 | 2020-09-02 | Mablink Bioscience | Ligand-drug-conjugate comprising a single molecular weight polysarcosine |
| CA3247730A1 (en) * | 2017-11-07 | 2025-10-30 | Regeneron Pharmaceuticals, Inc. | Hydrophilic linkers for antibody drug conjugates |
-
2020
- 2020-05-19 CA CA3140063A patent/CA3140063A1/en active Pending
- 2020-05-19 CN CN202411876882.8A patent/CN119613486A/zh active Pending
- 2020-05-19 JP JP2021568944A patent/JP2022533215A/ja active Pending
- 2020-05-19 AU AU2020279731A patent/AU2020279731B2/en active Active
- 2020-05-19 CN CN202411876945.XA patent/CN119613487A/zh active Pending
- 2020-05-19 CN CN202080036837.5A patent/CN113853219B/zh active Active
- 2020-05-19 KR KR1020217041090A patent/KR20220010527A/ko active Pending
- 2020-05-19 US US17/612,280 patent/US20230091510A1/en active Pending
- 2020-05-19 WO PCT/US2020/033648 patent/WO2020236841A2/en not_active Ceased
- 2020-05-19 EP EP20731697.7A patent/EP3972650A2/en active Pending
-
2021
- 2021-10-26 IL IL287596A patent/IL287596A/en unknown
-
2025
- 2025-04-08 AU AU2025202473A patent/AU2025202473A1/en active Pending
- 2025-09-01 JP JP2025144373A patent/JP2026000940A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1056162C (zh) | 聚胺化的配位体及其金属配合物 | |
| US7150882B2 (en) | Enhanced circulation effector composition and method | |
| JP2023512455A5 (cg-RX-API-DMAC7.html) | ||
| JP2023113639A (ja) | ビス-オクタヒドロフェナントレンカルボキサミド及びそのタンパク質コンジュゲート | |
| US20100160485A1 (en) | Hydrolysis stable self-etching, self-priming adhesive | |
| JP2022512643A5 (cg-RX-API-DMAC7.html) | ||
| AU2004201789A1 (en) | Fc receptor modulators and uses thereof | |
| RU98120057A (ru) | Производные d-пролина | |
| JP6051223B2 (ja) | ペプチドの放出可能な結合のためのチロシンに基づくリンカー | |
| JP2007535474A (ja) | 複合補体カスケードインヒビター | |
| WO2006088248A1 (ja) | ポリオキシアルキレン誘導体 | |
| JP2003506491A5 (cg-RX-API-DMAC7.html) | ||
| FI78300B (fi) | Foerfarande foer framstaellning av farmakologiskt verkande fosfatidylfoereningar. | |
| JP2020183404A (ja) | 第viii因子両性イオンポリマーコンジュゲート | |
| JP2008528549A (ja) | 構造的に充分に定義された分岐ポリマーと接合されたインスリン誘導体 | |
| JP2022512401A5 (cg-RX-API-DMAC7.html) | ||
| JP2024509282A5 (cg-RX-API-DMAC7.html) | ||
| JP2019507126A5 (cg-RX-API-DMAC7.html) | ||
| JP2024542021A5 (cg-RX-API-DMAC7.html) | ||
| EP0753004A1 (en) | Antagonists of endothelin receptors | |
| JP3274225B2 (ja) | アミノ酸誘導体及びその用途 | |
| JP2025514282A5 (cg-RX-API-DMAC7.html) | ||
| KR20070010175A (ko) | 온화한 가티올분해 조건하에서 방출될 수 있는 폴리머콘쥬게이트 | |
| RU2021137409A (ru) | Конъюгаты антитело-лекарственное средство, содержащие линкеры, содержащие гидрофильные группы | |
| RU2024138136A (ru) | Конъюгаты антитела и лекарственного средства |